Phosphodiesterase 4 inhibitors for psoriatic arthritis

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To evaluate the benefits and harms of PDE4 inhibitors (e.g., apremilast) for the treatment of PsA.

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cochrane Database Syst Rev
Main Authors: Zamora, Natalia V, Valerio‐Morales, Ignacio‐Alfredo, Lopez‐Olivo, Maria Angeles, Pan, Xin, Suarez‐Almazor, Maria E
Format: Artigo
Jezik:Inglês
Izdano: John Wiley & Sons, Ltd 2016
Teme:
Medicine General & Introductory Medical Sciences
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6457930/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012401
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki